Cardiorespiratory fitness and type 2 diabetes risk: A prospective cohort study with mediation analysis of biological aging in the UK Biobank
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.70261 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Xiangliang Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, The First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiorespiratory Fitness, Aging. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Department of Science and Technology of Jilin Province.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
Higher cardiorespiratory fitness is associated with reduced type 2 diabetes mellitus ( T2D ) risk, but the underlying mechanisms remain incompletely understood. We investigated whether biological aging mediates the association between maximal oxygen uptake ( VO 2 max) and incident T2D risk. Materials and Methods This prospective cohort study included 54 418 UK Biobank participants aged 39–70 years without baseline diabetes. VO 2 max was estimated using a validated algorithm incorporating resting heart rate, physical activity, age, sex and body mass index. Biological age (BA) and phenotypic age (PhenoAge) were calculated from clinical biomarkers. Cox proportional hazards models estimated hazard ratios ( HRs ) and 95% confidence intervals ( CIs ), adjusting for sociodemographic, lifestyle and clinical factors. Linear regression analyses assessed cross‐sectional associations between VO 2 max and standardised glycaemic and lipid biomarkers. Mediation analysis quantified the proportion of association explained by biological aging measures.
Results
During 694 986 person‐years of follow‐up, 2628 participants developed T2D (incidence rate: 3.78 per 1000 person‐years). Compared to the lowest VO 2 max quartile, participants in the highest quartile had a 56% lower T2D risk ( HR 0.44, 95% CI = 0.39–0.50). Each standard deviation increase in VO 2 max was associated with a 28% lower risk ( HR 0.72, 95% CI = 0.68–0.76). BA acceleration mediated 8.2% (95% CI = 6.1%–10.8%) and PhenoAge acceleration mediated 9.1% (95% CI = 6.8%–12.1%) of the VO 2 max– T2D association. Protective associations were consistent across sex, age, ethnicity and genetic risk subgroups. VO 2 max showed strong inverse correlations with glucose ( β = −0.32), glycated haemoglobin ( β = −0.28), triglycerides ( β = −0.31) and a positive correlation with high‐density lipoprotein ( HDL) cholesterol ( β = 0.29).
Conclusions
Higher cardiorespiratory fitness demonstrates robust protective associations against T2D incidence, with biological aging mechanisms partially mediating this relationship.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Center, The First Hospital of Jilin University, Changchun, China.
ORCID-Profile: Naifei Chen
Förderung
- Department of Science and Technology of Jilin Province
Zitieren
APA
Liu, X., Chen, X., Yang, W., Ding, G., Zhao, Y., Li, Y., Chen, N., & Cui, J. (2026). Cardiorespiratory fitness and type 2 diabetes risk: A prospective cohort study with mediation analysis of biological aging in the UK Biobank. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70261
Vancouver
Liu X, Chen X, Yang W, Ding G, Zhao Y, Li Y, et al. Cardiorespiratory fitness and type 2 diabetes risk: A prospective cohort study with mediation analysis of biological aging in the UK Biobank. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70261
BibTeX
@article{Liu2026,
author = {Liu, Xiangliang and Chen, Xinqiao and Yang, Wang and Ding, Guanran and Zhao, Yixin and Li, Yuguang and Chen, Naifei and Cui, Jiuwei},
title = {Cardiorespiratory fitness and type 2 diabetes risk: A prospective cohort study with mediation analysis of biological aging in the UK Biobank},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.70261}
}
EUVIMED